You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》上證受制3,600點關 深成創板半日跌0.5%-0.6% 中藥股逆市升
內地昨日(10日)新增本土確診病例110例。人行今日(11日)進行100億人民幣(下同)7天期逆回購操作,利率持平。人民幣兌美元中間價下調31點,上證深成微微低開後反覆偏軟,深成、創板表現較差。 上證曾見3,602,半日微跌2點或0.08%,收報3,590點,受制3,600點關;深成指跌78點或0.5%,收報14,328點;滬深300指數跌13點或0.3%,收報4,830點;創業板指數跌20點或0.7%,收報3,075點,成交1,427.5億元。上證深成半日成交分別爲2,654億元及3,747億元。 中資金融股靠穩,工行(601398.SH)及建行(601939.SH)分別升0.4%及0.3%。國壽(601628.SH)升1%。中國移動(600941.SH)跌0.8%,半日報58.34元。 數字貨幣概念股顯着回吐,雄帝科技(300546.SZ)、翠微股份(603123.SH)、新開普(300248.SZ)跌4.8%-8.4%。 中藥股強勢,開開實業(600272.SH)、昆藥集團(600422.SH)、衆生藥業(002317.SZ)漲停。 興業銀行(601166.SH)去年淨利潤增長24.1%,股價升3.8%。 華僑城A(000069.SZ)升2.6%,公司表示,三道紅線指標保持「綠檔」,資金及融資額度儲備上仍有充足空間。 寧德時代(300750.SZ)靠穩升0.2%。貴州茅臺(600519.SH)低開低走跌1%。(ta/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account